Reuters logo
BRIEF-Biocon says USFDA target action date for trastuzumab reset to Dec 3, 2017
August 30, 2017 / 10:41 AM / 24 days ago

BRIEF-Biocon says USFDA target action date for trastuzumab reset to Dec 3, 2017

Aug 30 (Reuters) - Biocon Ltd

* Says USFDA target action date for trastuzumab reset to December 3, 2017

* Says extension will have no impact on anticipated timetable for commercialization of product in US Source text - bit.ly/2wnyYbB Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below